|
|
Hepatitis C Virus Cell-Cell Transmission and Resistance to Direct-Acting Antiviral Agents
|
|
|
|
|
نویسنده
|
xiao f. ,fofana i. ,heydmann l. ,barth h. ,soulier e. ,habersetzer f. ,doffoël m. ,bukh j. ,patel a.h. ,zeisel m.b. ,baumert t.f.
|
منبع
|
plos pathogens - 2014 - دوره : 10 - شماره : 5
|
چکیده
|
Hepatitis c virus (hcv) is transmitted between hepatocytes via classical cell entry but also uses direct cell-cell transfer to infect neighboring hepatocytes. viral cell-cell transmission has been shown to play an important role in viral persistence allowing evasion from neutralizing antibodies. in contrast,the role of hcv cell-cell transmission for antiviral resistance is unknown. aiming to address this question we investigated the phenotype of hcv strains exhibiting resistance to direct-acting antivirals (daas) in state-of-the-art model systems for cell-cell transmission and spread. using hcv genotype 2 as a model virus,we show that cell-cell transmission is the main route of viral spread of daa-resistant hcv. cell-cell transmission of daa-resistant viruses results in viral persistence and thus hampers viral eradication. we also show that blocking cell-cell transmission using host-targeting entry inhibitors (hteis) was highly effective in inhibiting viral dissemination of resistant genotype 2 viruses. combining hteis with daas prevented antiviral resistance and led to rapid elimination of the virus in cell culture model. in conclusion,our work provides evidence that cell-cell transmission plays an important role in dissemination and maintenance of resistant variants in cell culture models. blocking virus cell-cell transmission prevents emergence of drug resistance in persistent viral infection including resistance to hcv daas. © 2014 xiao et al.
|
|
|
آدرس
|
inserm,u1110,strasbourg,france,université de strasbourg,strasbourg, France, inserm,u1110,strasbourg,france,université de strasbourg,strasbourg, France, inserm,u1110,strasbourg,france,université de strasbourg,strasbourg, France, inserm,u1110,strasbourg,france,université de strasbourg,strasbourg,france,laboratoire de virologie,hôpitaux universitaires de strasbourg,strasbourg, France, inserm,u1110,strasbourg,france,université de strasbourg,strasbourg, France, inserm,u1110,strasbourg,france,université de strasbourg,strasbourg,france,pôle hépato-digestif,hôpitaux universitaires de strasbourg,strasbourg, France, inserm,u1110,strasbourg,france,université de strasbourg,strasbourg,france,pôle hépato-digestif,hôpitaux universitaires de strasbourg,strasbourg, France, copenhagen hepatitis c program (co-hep),dept. of infectious diseases and clinical research ctr.,hvidovre hospital and department of international health,immunology and microbiology,university of copenhagen,copenhagen, Denmark, mrc-university of glasgow centre for virus research,glasgow, United Kingdom, inserm,u1110,strasbourg,france,université de strasbourg,strasbourg, France, inserm,u1110,strasbourg,france,université de strasbourg,strasbourg,france,pôle hépato-digestif,hôpitaux universitaires de strasbourg,strasbourg,france,gastrointestinal unit,massachusetts general hospital,harvard medical school,boston,ma, United States
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|